Salicylate blockade of granulocyte adherence and the inflammatory response to experimental peritonitis

Blood
|May 1, 1979
PubMed

Insights

Aspirin and sodium salicylate impair granulocyte adherence and function. This aspirin effect on immune cells may lead to increased susceptibility to bacterial infections and higher mortality rates.

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • Bacterial products like endotoxin can stimulate granulocyte adherence.
  • Granulocyte adherence is crucial for effective immune response against pathogens.

Purpose of the Study:

  • To investigate the effect of aspirin and sodium salicylate on granulocyte adherence and function.
  • To determine the impact of aspirin on the immune response to bacterial infections.

Main Methods:

  • In vitro assays measuring granulocyte adherence to nylon fiber after stimulation with bacterial products.
  • In vivo studies involving pretreatment of mice with sodium salicylate followed by bacterial infection.

Main Results:

  • Aspirin significantly inhibited granulocyte adherence induced by Escherichia coli endotoxin and Staphylococcus aureus culture filtrate.
  • Granulocytes from aspirin-ingesting volunteers showed diminished response to endotoxin.
  • Sodium salicylate pretreatment in mice impaired granulocyte exudation, leading to uncontrolled bacteremia and increased mortality.

Conclusions:

  • Aspirin and its metabolite sodium salicylate can suppress key granulocyte functions.
  • These findings suggest a potential mechanism by which aspirin may increase susceptibility to bacterial infections.

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...